Form 4: Harvard Apparatus Regenerative Technology CEO Buys Shares
Insider Transaction (Form 4)
Junli He, CEO and a Director of Harvard Apparatus Regenerative Technology, Inc., purchased 368,630 shares of common stock on September 11, 2026.
Summary
- Conversion of derivative: acquired 683,725 Common Stock at $1.05 ($717,911) on September 11, 2026; holds 964,300 after (Direct).
- Open-market purchase: acquired 361,905 Common Stock at $1.05 ($380,000) on September 11, 2026; holds 1,326,205 after (Direct).
- Open-market purchase: acquired 6,725 Common Stock at $2.15 ($14,459) on September 15, 2026; holds 1,332,930 after (Direct).
- Conversion of derivative: disposed of 310,000 Bridge Note (04/14/2026) on September 11, 2026 (Direct).
- Conversion of derivative: disposed of 205,378 Bridge Note (05/13/2026) on September 11, 2026 (Direct).
- Conversion of derivative: disposed of 202,533 Bridge Note (07/16/2026) on September 11, 2026 (Direct).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $394,459, committing personal capital to the stock.
Insider Transactions
Junli He — Director, Officer (CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Conversion of derivative | Common Stock | 683,725 | $1 | $717.9K | 964,300 |
| 2026-09-11 | Open-market purchase | Common Stock | 361,905 | $1 | $380.0K | 1,326,205 |
| 2026-09-15 | Open-market purchase | Common Stock | 6,725 | $2 | $14.5K | 1,332,930 |
| 2026-09-11 | Conversion of derivative | Bridge Note (04/14/2026) | 310,000 | — | — | 0 |
| 2026-09-11 | Conversion of derivative | Bridge Note (05/13/2026) | 205,378 | — | — | 0 |
| 2026-09-11 | Conversion of derivative | Bridge Note (07/16/2026) | 202,533 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Conversion of derivative (683,725 shares) |
| 2026-09-11 | Open-market purchase (361,905 shares) |
| 2026-09-15 | Open-market purchase (6,725 shares) |
| 2026-09-11 | Conversion of derivative (310,000 shares) |
| 2026-09-11 | Conversion of derivative (205,378 shares) |
| 2026-09-11 | Conversion of derivative (202,533 shares) |
Keywords
insider transaction, Form 4, HRGN, Harvard Apparatus Regenerative Technology, Inc., bullish, Junli He
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.